Literature DB >> 15629724

Mammalian SCAN domain dimer is a domain-swapped homolog of the HIV capsid C-terminal domain.

Dmitri Ivanov1, James R Stone, Jenny L Maki, Tucker Collins, Gerhard Wagner.   

Abstract

Retroviral assembly is driven by multiple interactions mediated by the Gag polyprotein, the main structural component of the forming viral shell. Critical determinants of Gag oligomerization are contained within the C-terminal domain (CTD) of the capsid protein, which also harbors a conserved sequence motif, the major homology region (MHR), in the otherwise highly variable Gag. An unexpected clue about the MHR function in retroviral assembly emerges from the structure of the zinc finger-associated SCAN domain we describe here. The SCAN dimer adopts a fold almost identical to that of the retroviral capsid CTD but uses an entirely different dimerization interface caused by swapping the MHR-like element between the monomers. Mutations in retroviral capsid proteins and functional data suggest that a SCAN-like MHR-swapped CTD dimer forms during immature particle assembly. In the SCAN-like dimer, the MHR contributes the major part of the large intertwined dimer interface explaining its functional significance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629724     DOI: 10.1016/j.molcel.2004.12.015

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  43 in total

1.  Conformation of the HIV-1 Gag protein in solution.

Authors:  Siddhartha A K Datta; Joseph E Curtis; William Ratcliff; Patrick K Clark; Rachael M Crist; Jacob Lebowitz; Susan Krueger; Alan Rein
Journal:  J Mol Biol       Date:  2006-10-26       Impact factor: 5.469

2.  Domain-swapped dimerization of the HIV-1 capsid C-terminal domain.

Authors:  Dmitri Ivanov; Oleg V Tsodikov; Jeremy Kasanov; Tom Ellenberger; Gerhard Wagner; Tucker Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

3.  Ty3 capsid mutations reveal early and late functions of the amino-terminal domain.

Authors:  Liza S Z Larsen; Min Zhang; Nadejda Beliakova-Bethell; Virginia Bilanchone; Anne Lamsa; Kunio Nagashima; Rani Najdi; Kathryn Kosaka; Vuk Kovacevic; Jianlin Cheng; Pierre Baldi; G Wesley Hatfield; Suzanne Sandmeyer
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

4.  Flexibility in HIV-1 assembly subunits: solution structure of the monomeric C-terminal domain of the capsid protein.

Authors:  Luis A Alcaraz; Marta del Alamo; Francisco N Barrera; Mauricio G Mateu; José L Neira
Journal:  Biophys J       Date:  2007-05-25       Impact factor: 4.033

5.  Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells.

Authors:  Hua Li; Jun Dou; Lingmei Ding; Paul Spearman
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

Review 6.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

7.  Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly.

Authors:  John G Purdy; John M Flanagan; Ira J Ropson; Kristen E Rennoll-Bankert; Rebecca C Craven
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

8.  Cooperative role of the MHR and the CA dimerization helix in the maturation of the functional retrovirus capsid.

Authors:  Parvez M Lokhandwala; Tam-Linh N Nguyen; J Bradford Bowzard; Rebecca C Craven
Journal:  Virology       Date:  2008-04-22       Impact factor: 3.616

Review 9.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

10.  Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein.

Authors:  Brian N Kelly; Sampson Kyere; Isaac Kinde; Chun Tang; Bruce R Howard; Howard Robinson; Wesley I Sundquist; Michael F Summers; Christopher P Hill
Journal:  J Mol Biol       Date:  2007-08-15       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.